ClassID:

111235

C12N2770/18034 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Comoviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20250242059
2025-07-31

CORONAVIRUS VACCINE

#2
20250000964
2025-01-02

NEOADJUVANT USAGE OF PLANT VIRUS OR VIRUS-LIKE PARTICLES FOR CANCER TREATMENT

#3
20240390524
2024-11-28

RNA CONSTRUCTS AND USES THEREOF

#4
20240226275
2024-07-11

Compositions and methods of mRNA vaccines against novel coronavirus infection

#5
20240209325
2024-06-27

CANCER PROPHYLAXIS AND THERAPY USING TARGETED VIRAL NANOPARTICLES

#6
20240207187
2024-06-27

DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY

#7
20240075165
2024-03-07

Coronavirus vaccine

#8
20230075979
2023-03-09

Coronavirus vaccine

#9
20230058789
2023-02-23

SARS-COV-2 CHIMERIC VLP VACCINE COMPOSITION, EXPRESSING VECTOR AND USE THEREOF

#10
20220273820
2022-09-01

RNA constructs and uses thereof

#11
20220249704
2022-08-11

RNA constructs and uses thereof

#12
20220135625
2022-05-05

SARS-CoV-2 viruses and methods of use thereof

#13
20210347828
2021-11-11

RNA Replicon Encoding a Stabilized Corona Virus Spike Protein

#14
20210299249
2021-09-30

Recombinant multivalent influenza viruses

#15
20210180027
2021-06-17

Method for acclimating and suspending Vero and second order production process for virus

#16
20180008699
2018-01-11

Vaccines for porcine epidemic diarrhea virus infections

#17
20160008457
2016-01-14

Inactivated Vaccine for Porcine Epidemic Diarrhea Virus (PEDV)

#18
18670452
2025-07-22

Conserved region T cell vaccines for coronavirus and methods of use

#19
17234590
2024-07-02

Conserved region T cell vaccines for coronavirus and methods of use

#20
17233396
2023-01-10

Coronavirus vaccine

#21
17173617
2022-01-18

Mouse-adapted SARS-CoV-2 viruses and methods of use thereof